Cano Health (CANO) Misses Q2 EPS by 1c, Offers Guidance

Cano Health (NYSE: CANO) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $689.4 million versus the consensus estimate of $712.61 million.

GUIDANCE:

Cano Health sees FY2022 revenue of $2.85-2.9 billion, versus the consensus of $2.86 billion.

For earnings history and earnings-related data on Cano Health (CANO) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Paychex (PAYX) Tops Q1 EPS by 2c
• H.B. Fuller (FUL) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance